Edoardo Cignoli : Novartis Frets Over Japan Studies

The head of the pharmaceuticals division of Novartis said that he was concerned more about reputational damage than a sales hit from questions raised over studies done by Japanese universities on its blockbuster heart medicine Diovan.



via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304906704579112923475047910.html?mod=pls_whats_news_us_business_f